Podcasts about Tessera

Dans l'actu des nouvelles technologies et de l'accessibilité cette semaine : Du côté des applications et du web Utiliser plusieurs langues avec NVDA. Windows 11 teste de nouvelles fonctions d'accessibilité ; teinte de l'écran, prise en charge améliorée du braille et plusencore. Tessera, un nouveau client RSS pour Android. Supertonic TTS Android : Un autre moteur vocal d'IA hors ligne rejoint la vague TTS open-source. Voxiweb fait peau neuve sur iOS. EchoScape pour iOS : L'assistant de navigation spatiale 3D pour déficients visuels. TurboMeta — L'application Ray-Ban Meta dotée de fonctionnalités utiles pour les déficients visuels. Sparkle, un logiciel de nettoyage et optimisation pour windows de nouvelle génération. Amazon lance Alexa+ en France : l'assistante IA nouvelle génération s'appuie sur Mistral AI. Anthropic, l'éditeur du LLM Claude, recrute un ingénieur en accessibilité. La société Touch2See qui développait une tablette pour suivre les sports collectifs a mis fin à son activité. Nous les avions interviewé. Mise à jour de l'application Orange TV sur iOS, retour du champ de recherche. Lenteur dans Mail sur macOS avec VoiceOver ? Désactiver la fonction Résumé dans Mail. Le reste de l'actu Les cartes bancaires de la Banque Populaire et de la Caisse d'Épargne ajoute du braille pour identification. Un chercheur crée un gillet aptic pour une alpiniste sourde-aveugle qui s'attaque à l'Everest. Ontrack, des lunettes audio pour sportifs. Foire Aux Questions Cette semaine, une question de Alice à propos de Airplay sur des Homepods. Remerciements Cette semaine, nous remercions Christophe, Cotton, Philippe, Nagib, Nicolas, Saadi, Sebastian, Tony et Vincent pour leurs infos ou leur dons. Si vous rsouhaitez vous aussi nous envoyer de l'info ou nous soutenir : Pour nous contactez ou nous envoyez des infos, passez par le formulaire de contact sur la page oxytude.org/contact. Pour nous soutenir via Paypal, c'est sur la page paypal.me/oxytude. Pour vos achats sur Amazon, passez par notre lien affilié oxytude.org/amazon.. Pour animer cet épisode Cédric, Philippe et Yannick.

Chan Ahn is the founder of Tessera and a 17-year veteran of Wall Street. He joins Alex Perny to explain how blockchain tokenization is opening private markets to retail investors. This episode covers pre-IPO investing, atomic settlement, counterparty risk, on-chain proof of reserve, stablecoins, and the regulatory outlook for tokenized assets.Key Points:- Private markets are restricted due to settlement risk and information asymmetry, not just regulation- Blockchain enables atomic settlement: buyer and seller transact simultaneously with no delay and no counterparty trust required- Tessera houses assets in a Cayman segregated portfolio and uses Chainlink for 24/7 on-chain verification- SpaceX tokens trade on-chain at $1.5 to $1.66 trillion, a discount to the $1.75 to $2 trillion institutional target- Tokenized assets total roughly $30 billion today and are growing at 200% year over year- McKinsey projects the tokenized asset market reaches $2 trillion by 2030 out of a $300 trillion addressable market- Blockchain will compress a decade of TradFi market evolution into one to two years- Dollar-denominated stablecoins serve as the primary liquidity layer for tokenized private market assetsChapters:0:00 Introduction2:12 Chan's background: Goldman Sachs, JPMorgan, and founding Tesera6:37 Why private markets exist: settlement risk and information asymmetry13:16 How atomic settlement works on blockchain20:19 Converting off-chain private equity into on-chain tokens26:53 Liquidity, price discovery, and trading tokenized assets32:10 Do private companies benefit from blockchain valuation transparency?34:31 The disclosure challenge blockchain cannot solve alone42:01 Derivatives, lending, and the next phase of tokenized markets47:39 Stablecoins, FX risk, and liquidity standards51:09 The $300T addressable market and the path to $2T by 203055:15 Why tokenization is a win for both companies and investorsSubscribe to our YouTube channel and join our growing community for new videos every week.If you are interested in being a podcast guest speaker or have questions, contact us at ⁠⁠⁠⁠⁠⁠⁠⁠Podcast@AdvantaIRA.com⁠⁠⁠⁠⁠⁠⁠⁠.Learn more about our guest, Chan Ahn:https://www.tessera.pe/Learn more about Advanta IRA: https://www.AdvantaIRA.com/ https://podcasters.spotify.com/pod/show/advanta-irahttps://www.linkedin.com/company/Advanta-IRA/https://twitter.com/AdvantaIRA https://www.facebook.com/AdvantaIRA/ https://www.instagram.com/AdvantaIRA/#BlockchainInvesting #PreIPO #Tokenization #DeFi #PrivateMarkets #RWA #AlternativeInvesting #Tesera #ChanAhn #CryptoFinance

En este episodio arrancamos entrevistando a los desarrolladores de The Zibbo Show de Tessera Studios y después nos metimos de lleno en la telenovela del DRM de PlayStation, con Sony improvisando, rectificando y dejando a medio internet echando humo; también repasamos qué pasa en otras plataformas, desde el aviso de Intel sobre la subida de precios de CPUs por culpa de la IA hasta el nuevo Steam Controller de Valve, el estudio que dice que jugar a Pokémon de pequeño te deja una región especial en el cerebro y ese indie deliciosamente cruel en el que tu backlog de Steam se convierte en tu peor pesadilla. Además, hablamos de lanzamientos como Aphelion, Neverness to Everness y ese Resident Evil “good vibes” que tú sí te jugarías, mientras también comentamos rarezas como la réplica de un juego de Switch 2 hecha con impresora 3D y el debate absurdo sobre si los cruces de botiquines verdes violarían la Convención de Ginebra.

 sat down with Chan, founder of Tessera Labs, to explore how they are tearing down the walls around private equity investing. Chan spent over a decade at Goldman Sachs, JP Morgan, and Credit Suisse before doing a PhD in computational finance at Imperial College London. He saw first hand that the best returns in private markets were locked behind accreditation requirements, massive minimum tickets, and years of illiquidity. Tessera is his answer to that. We talk about how they tokenized SpaceX participation rights on Solana, why they chose Chainlink for proof of reserve, how $75 million in trading volume happened in just a few months, and what their next product T-Kalshi means for everyday investors who want exposure to one of the hottest prediction market companies in the US right now. We also get into the legal architecture behind the Cayman SPC structure, why no KYC is intentional and not an oversight, the challenges of building in a regulatory gray zone, and what Chan would tell any founder building in the RWA space today. Nothing mentioned in this podcast is investment advice and please do your own research. It would mean a lot if you can leave a review of this podcast on Apple Podcasts or Spotify and share this podcast with a friend. Be a guest on the podcast or contact us - https://www.web3pod.xyz/--- CONNECT ---Tessera Website: https://tessera.peTwitter/X: https://twitter.com/tesseralabsWeb3 with Sam Kamani: https://www.web3pod.xyz/--- KEY POINTS WITH TIMESTAMPS ---• [00:00] Sam introduces Chan from Tessera Labs and the goal of disrupting the multi-trillion dollar private equity market• [01:03] Chan shares his background across Goldman Sachs, JP Morgan, and Credit Suisse plus his PhD in computational finance at Imperial College• [02:28] The three interlocking problems Tessera solves: access, liquidity, and transparency in private equity• [04:25] A step-by-step walkthrough of how an investor gets exposure to Kalshi private shares through tessera.pe with no KYC and no minimum• [06:34] Why Kalshi's US regulatory access gave it a major revenue advantage over Polymarket• [08:13] Four advantages of tokenized private equity over traditional VC and PE funds including $75 million in T-SpaceX trading volume• [11:13] The two early user groups: crypto-native retail investors and trade professionals in Asia and MENA• [12:34] The hardest parts of bringing real world assets on chain: legal structure, Oracle design, and MPC custody• [14:31] How Tessera uses Chainlink proof of reserve, Cayman SPC legal isolation, and Fireblocks MPC to build trust• [16:29] Why Tessera chose Solana over Ethereum, BASE, and Arbitrum including Token 22 transfer hooks• [18:56] Advice for RWA founders: design for retail-native access first, get legal architecture right before product, and choose your Oracle carefully• [21:53] What Chan would do differently if starting Tessera Labs again today• [24:06] The biggest challenge ahead: navigating a regulatory landscape that recognises the space but has not yet legislated it• [26:25] Plans for staking and using T-tokens as collateral for borrowing and lending yield• [27:58] Why Tessera will stay focused on late-stage pre-IPO names for now and the opportunity around IPO lockup periods• [30:12] Chan's three asks: users to try tessera.pe, secondary liquidity partners to get in touch, and strategic investors who share the vision

⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Vai, scopri di più su Melinda e la collaborazione con AIRC! Perché per votare dovevi portarti dietro il cognome di tuo marito? Storia di una norma nata nel dopoguerra e demolita solo adesso, tra diritto, burocrazia e patriarcato tipografico. #cosemoltoumane#storiaditalia#dirittidonnE#patriarcato#burocraziaitaliana#storiadelvoto#cognome#tesseraelettorale#paritàdigenere#costituzione ⁠Vai su Klarna e ottieni flessibilità e cashback, tutto in un'unica app per pagamenti, premi, shopping intelligente e controllo delle tue finanze. Learn more about your ad choices. Visit megaphone.fm/adchoices

Svolta tecnologica a Thiene nel campo della raccolta dei rifiuti all'insegna della sostenibilità e del concetto virtuoso del “chi meno inquina meno paga”. La rivoluzione dei cassonetti dei rifiuti indifferenziati è iniziata il 19 gennaio. Le campane si apriranno con una tessera (scaricabile anche sul telefono) che consentirà il conteggio degli svuotamenti e di avere una bolletta calcolata in base al proprio consumo.

Scopriamo le novità di oggi dal mondo Tesla!Se vuoi supportare il canale con una donazione:

Una proposta di legge in Italia intende estendere l'accesso al Servizio Sanitario Nazionale agli italiani residenti all'estero, ma non gratuitamente.

Send us a textGood morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we'll explore the latest advances and strategic moves shaping the industry, providing you with insights into how these developments might influence drug development and patient care.The pharmaceutical and biotech sectors are currently experiencing a wave of transformative changes. A significant development is the trade agreement between the United States and the United Kingdom, which excludes medicines from import tariffs. This strategic move, orchestrated by the Trump administration, is set to reduce costs and bolster investments in pharma sectors across both nations. By enhancing market accessibility, it aims to stimulate cross-border investment in pharmaceutical research and production.On the clinical front, Eli Lilly is making headlines by joining Novo Nordisk in reducing self-pay prices for its GLP-1 receptor agonist, Zepbound. This reflects a broader industry trend towards patient-centric pricing models aimed at improving affordability. With healthcare costs on the rise, these measures could ease financial burdens for patients requiring long-term medication regimens.Regulatory updates are also making waves, with the FDA planning stricter vaccine regulations under Dr. Vinay Prasad's leadership at the Center for Biologics Evaluation and Research (CBER). These updates come amid concerns over vaccine safety during COVID-19-related incidents, underscoring a commitment to maintaining public trust in vaccines. Regulatory scrutiny continues as Prasad focuses on COVID-19 vaccine safety in children amid reports linking 10 child deaths to vaccines via VAERS—emphasizing challenges interpreting safety data while highlighting the need for robust methodologies ensuring reliable causality conclusions.In corporate restructuring news, Valneva is streamlining its operations by closing a site and eliminating 30 roles. This move highlights an industry focus on optimizing resources to bolster vaccine development pipelines. Meanwhile, Microsize and Schedio's acquisition of Lonza's Swiss micronization plant underscores ongoing investments in advanced manufacturing technologies critical for high-quality pharmaceuticals.In ophthalmology, Belite Bio is advancing with promising Phase 3 results for tinlarebant in treating Stargardt disease—a rare genetic eye disorder. This success positions Belite to file for FDA approval, potentially expanding treatment options for this underserved patient population. Such advancements in targeted therapies emphasize the need for ongoing research in genetic disorders.Regeneron is betting $150 million on Tessera's gene writing technology targeting alpha-1 antitrypsin deficiency (AATD). This collaboration highlights the industry's growing interest in gene therapy as a frontier for treating rare diseases, marking a shift towards precision medicine where tailored genetic interventions offer hope for previously untreatable conditions. Regeneron's strategic move investing $275 million partnering with Tessera exploring gene editing capabilities—focusing on TSRA-196 targeting the SERPINA1 gene linked to AATD showcases potential advancing therapeutic options for genetic disorders through gene editing technologies offering new disease treatment avenues.AI-driven platforms were spotlighted at RSNA 2025 by industry leaders such as GE Healthcare, Philips, and Siemens. These innovations promise to revolutionize radiological workflows by enhancing diagnostic accuracy and operational efficiency through AI integration. As AI continues to permeate healthcare technologies, its potential to transform diagnostic processes marks a significant leap towards personalized medicine.Akebia Therapeutics' acquisition ofSupport the show

In this exciting episode of the Appelboom Podcast, host Joost Appelboom is joined by Azizah from GourmetPens and special guest Kate from BENU Pens! We celebrate Fountain Pen Day and dive deep into the brand-new BENU collection for 2025. Kate gives us an exclusive first look at the stunning new Haute Collection release, and we explore the latest updates on the Tessera and Pixie pens.Joost also introduces two incredible new arrivals on the Appelboom website:✨ Montegrappa Sea Shepherd – Caretta caretta✨ Leonardo Cigar LeonArco Mother of Pearl – Authentic CelluloidAs always, the audience contributed amazing questions and insights, making this another inspiring and interactive fountain pen conversation.

Da quest'anno l'Agenzia delle Entrate potrà consultare direttamente i dati delle spese sanitarie e veterinarie trasmessi al Sistema tessera sanitaria per verificare la correttezza delle detrazioni indicate nei modelli 730 e Redditi. La novità è contenuta nel decreto del ministero dell'Economia e delle Finanze del 29 ottobre scorso.

Im Rahmen der Roche Young Commissions 2025 präsentieren zwei herausragende junge Komponisten ihre neuen Orchesterwerke am Lucerne Festival: Guillem Palomar (Spanien) und Jakob Raab (Deutschland). Palomars Stück «Tessera» versteht sich als musikalisches Mosaik: Inspiriert von antiken wie modernen Mosaikkunstformen, etwa den Trencadís-Arbeiten Gaudís, setzt er sein Werk aus kleinsten musikalischen Einheiten zusammen – rhythmisch, klanglich, strukturell. Wie die Teile eines Mosaiks behalten auch seine musikalischen «Tesserae» ihre Individualität, formen zugleich aber eine vielschichtige Gesamtstruktur. Das Werk entfaltet sich in drei Teilen und stellt die Beziehung zwischen Form, Struktur und Emotion ins Zentrum. Jakob Raab wiederum widmet sich in «malo» einem Kindheitseindruck: Der Oper «The Turn of the Screw» von Benjamin Britten. Der gleichnamige Kinderreim aus der Oper – einfach, aber mehrdeutig – liefert die emotionale und musikalische Grundlage des Werks. Raab dekonstruiert und transformiert das Material subtil, ohne es direkt zu zitieren, und hinterfragt so auf persönliche Weise die Rolle musikalischer Erinnerung im Kompositionsprozess. Lucerne Festival Academy 3: Guillem Palomar: Tessera für Orchester (Uraufführung «Roche Young Commissions») Jakob Raab: malo für Orchester (Uraufführung «Roche Young Commissions») Dieter Ammann: No templates für Viola und Orchester Tabea Zimmermann, Viola Lucerne Festival Contemporary Orchestra (LFCO) Michelle Di Russo, Leitung (Palomar) Sebastian Zinca, Leitung (Raab) David Robertons (Ammann) Konzert vom 30. August 2025, KKL Luzern, Konzertsaal (Lucerne Festival) Portraits und Konzert sind in einer zweistündigen, durchgehenden Sendung kombiniert. Die Sendung steht unbeschränkt zum Nachhören zur Verfügung.

Derek Champagne talks with Sramana Mitra. Sramana is the founder and CEO of One Million by One Million (1Mby1M), the world's first and only global virtual incubator/accelerator. Its goal is to help a million entrepreneurs globally reach a million dollars in annual revenue, build a trillion dollars in global GDP, and create 10 million jobs.Since its founding in 2010, 1Mby1M has become a powerful platform for democratization of entrepreneurship acceleration.Sramana also developed 1Mby1M's Incubator-in-a-Box methodology for Corporate Incubation that is used by enterprises to manage internal and external innovation endeavors.In 2015, LinkedIn named Sramana one of their Top 10 Influencers alongside Bill Gates and Richard Branson.Sramana has been an entrepreneur and a strategy consultant in Silicon Valley since 1994. Her fields of experience span from hardcore technology disciplines like Artificial Intelligence, Cloud Computing and Semiconductors, to sophisticated consumer marketing industries including e-commerce, fashion and education.As an entrepreneur CEO, Sramana founded three companies: Dais (off-shore software services), Intarka (sales lead generation and qualification software using Artificial Intelligence algorithms; VC: NEA) and Uuma (online personalized store for selling clothes using Expert Systems software; VC: Redwood). Two of these were acquired, while the third received an acquisition offer from Ralph Lauren which the company did not accept.As strategy consultant, Sramana has consulted with over 80 companies, including public companies such as SAP, Cadence Design Systems, Webex, KLA-Tencor, Best Buy, MercadoLibre and Tessera among others. Her work has also included numerous startups and VCs.Sramana has a Masters degree in EECS from MIT and a Bachelors degree in Computer Science and Economics from Smith College.From 2000 to 2004, Sramana chaired the MIT Club of Northern California's entrepreneurship program in Silicon Valley.Learn more at www.1Mby1M.comBusiness Leadership Series Intro and Outro music provided by Just Off Turner: https://music.apple.com/za/album/the-long-walk-back/268386576

Jill Upton and Sam Isherwood find out what happens when 4 creative people get together over some great bottles of wine. Tessera is a story that challenges the normal wine producers' thinking. @thewineshowaustralia @tesserawines_

Ieri il Senato ha approvato in via definitiva, o anzi, sarebbe meglio dire, ha convertito in legge il cosiddetto “decreto Flussi”, cioè il decreto legge emanato dal governo che contiene misure che riguardano, appunto, la gestione dei flussi migratori. Parliamo di cosa cambia. Intanto a causa di una norma che obbliga le scuole a gestire le spese sopra i 140mila euro con appalti pubblici complicati, molti dirigenti stanno annullando le gite scolastiche, mentre per chi ha l'app IO è finalmente possibile inserire la patente e il codice fiscale. Qui per la Promo Natale ... Qui il link per iscriversi al canale Whatsapp di Notizie a colazione: https://whatsapp.com/channel/0029Va7X7C4DjiOmdBGtOL3z Per iscriverti al canale Telegram: https://t.me/notizieacolazione ... Qui gli altri podcast di Class Editori: https://milanofinanza.it/podcast Musica https://www.bensound.com Learn more about your ad choices. Visit megaphone.fm/adchoices

Ansa - di Federica Liberotti. Al via per 43 milioni di persone. Butti, 'rivoluzione digitale'.

On today's episode, we're turning our focus to a pivotal innovation that has transformed design and manufacturing processes: flexible circuits.Flexible circuits have emerged as a game-changer in the manufacturing and design of electronic assemblies. With their unique ability to bend, twist, and conform to complex shapes, they offer unparalleled advantages in applications where space is at a premium and reliability is paramount. From wearable technology and medical devices to aerospace systems and consumer electronics, the use of flexible circuits has expanded rapidly, bringing with it both opportunities and challenges.In this episode, we'll explore the evolution of flexible circuit technology, discussing its key benefits, such as lightweight construction, enhanced durability, and improved design freedom. We'll also touch on the manufacturing complexities, material considerations, and the critical role that process control plays in ensuring reliability and performance.My guest today is Joseph Fjelstad. Joe is the founder of Verdant Electronics. Joseph Fjelstad has been active in electronics manufacturing since 1972 in various roles, including as a chemist, process engineer, and R&D manager. He holds nearly 190 U.S. Patents and numerous foreign ones. He is an internationally recognized expert, inventor and lecturer in the field of electronics interconnection technology and a veteran of several startup companies, including: Beta Phase, ELF Technologies, MetaRAM, Silicon Pipe, and Tessera (now the public company, Xperi).Some of Joe's innovative devices and novel reliability improving IC packaging structural features are found in nearly every electronic device made today. He is also an author, co-author or editor of several books on interconnection technology, including Flexible Circuit Technology 4th Edition, the most widely distributed reference book on the topic, Chip Scale Packaging for Modern Electronics, and Solderless Assembly For Electronics — The SAFE Approach. In addition, Fjelstad has written hundreds of articles, columns and commentaries for various industry magazines and journals over the last five decades. And today, he's the guest on my show.Here is a list of Joe's books:Flexible Circuit Technology 4th Editionhttps://iconnect007.com/my-i-connect007/books/flex-circuit-technologyChip Scale Packaging for Modern Electronicshttps://www.emerald.com/insight/content/doi/10.1108/cw.2004.21730bae.001/full/htmlSolderless Assembly for Electronics: The SAFE Approachhttps://iconnect007.com/my-i-connect007/books/solderless-assembly-electronics-safe-approach#:~:text=SAFE%20technology%20(Solderless%20Assembly%20For,design%20efficacy%2C%20reliability%20and%20security.Joe's Company:Verdant Electronicshttps://verdantelectronics.net Chapters:00:00:00 Importance of Flexible Circuits in Modern Electronics  00:02:42 Exploring the World of Flexible Circuits  00:05:30 Introduction to Flexible Circuits: A Historical Perspective00:08:43 Entrepreneurship Mindset: Naivety and Innovation00:11:08 The Value of Naivety in Engineering  00:13:43 Innovations in Bubble Printing Technology  00:16:47 Understanding Flex Circuits: Applications and Challenges00:19:58 The Lifespan and Failure of Torsion Bars  00:22:21 Evolution of Soldier Technology: From Heads-Up Displays to Wearables00:25:24 The Origins of the Integrated Circuit00:28:13 Advances in Microelectronics: From Printed Transistors to Modern Tech00:31:28 Challenges and Solutions in Flexible Circuit Design00:34:00 Collaborative Design for Efficient Manufacturing  00:36:49 Advances in Flexible HDI and the Upcoming Ultra HDI Conference  00:39:46 Evolution of Flexible Circuits: From 1903 to Present   00:42:40 Innovating Flexible Circuits  00:45:13 Evolution of Toll Road Technology00:48:08 The Future of Flexible and Stretchable Circuits00:51:53 Introduction to Verdant Electronics  00:54:46 The Military's Stance on Lead-Free Technology  00:56:27 Innovating Solderless Technology00:59:18 Insights on Persistence and Success in Entrepreneurship

On today's episode, we're turning our focus to a pivotal innovation that has transformed design and manufacturing processes: flexible circuits. Flexible circuits have emerged as a game-changer in the manufacturing and design of electronic assemblies. With their unique ability to bend, twist, and conform to complex shapes, they offer unparalleled advantages in applications where space is at a premium and reliability is paramount.  From wearable technology and medical devices to aerospace systems and consumer electronics, the use of flexible circuits has expanded rapidly, bringing with it both opportunities and challenges. In this episode, we'll explore the evolution of flexible circuit technology, discussing its key benefits, such as lightweight construction, enhanced durability, and improved design freedom.  We'll also touch on the manufacturing complexities, material considerations, and the critical role that process control plays in ensuring reliability and performance. Mike Konrad's guest today is Joseph Fjelstad. Joe is the founder of Verdant Electronics. Joseph Fjelstad has been active in electronics manufacturing since 1972 in various roles, including as a chemist, process engineer, and R&D manager. He holds nearly 190 US patents and numerous foreign ones.  He is an internationally recognized expert, inventor and lecturer in the field of electronics interconnection technology and a veteran of several startup companies, including: Beta Phase, ELF Technologies, MetaRAM, Silicon Pipe, and Tessera (now the public company, Xperi). Some of Joe's innovative devices and novel reliability improving IC packaging structural features are found in nearly every electronic device made today.  He is also an author, co-author or editor of several books on interconnection technology, including Flexible Circuit Technology 4th Edition, the most widely distributed reference book on the topic, Chip Scale Packaging for Modern Electronics, and Solderless Assembly For Electronics — The SAFE Approach.  In addition, Fjelstad has written hundreds of articles, columns and commentaries for various industry magazines and journals over the last five decades. And today, he's the guest on my show. 00:00:00 Importance of Flexible Circuits in Modern Electronics   00:02:42 Exploring the World of Flexible Circuits   00:05:30 Introduction to Flexible Circuits: A Historical Perspective 00:08:43 Entrepreneurship Mindset: Naivety and Innovation 00:11:08 The Value of Naivety in Engineering   00:13:43 Innovations in Bubble Printing Technology   00:16:47 Understanding Flex Circuits: Applications and Challenges 00:19:58 The Lifespan and Failure of Torsion Bars   00:22:21 Evolution of Soldier Technology: From Heads-Up Displays to Wearables 00:25:24 The Origins of the Integrated Circuit 00:28:13 Advances in Microelectronics: From Printed Transistors to Modern Tech 00:31:28 Challenges and Solutions in Flexible Circuit Design 00:34:00 Collaborative Design for Efficient Manufacturing   00:36:49 Advances in Flexible HDI and the Upcoming Ultra HDI Conference   00:39:46 Evolution of Flexible Circuits: From 1903 to Present    00:42:40 Innovating Flexible Circuits   00:45:13 Evolution of Toll Road Technology 00:48:08 The Future of Flexible and Stretchable Circuits 00:51:53 Introduction to Verdant Electronics   00:54:46 The Military's Stance on Lead-Free Technology   00:56:27 Innovating Solderless Technology 00:59:18 Insights on Persistence and Success in Entrepreneurship

We love to hear from our listeners. Send us a message.Tessera Therapeutics' CEO, Dr. Michael Severino, joins Host Erin Harris to discuss Gene Writing, the biotech's genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Severino discusses why delivery has always been a challenge for gene editing technologies and why Gene Writing is different when it comes to efficient delivery.

Mancano due giorni e mezzo alle elezioni europee: un piccolo recap su come si vota, approfittandone per dirvi grazie!

Sramana Mitra is the founder and CEO of One Million by One Million (1Mby1M), the world's first and only global virtual incubator/accelerator. Its goal is to help a million entrepreneurs globally reach a million dollars in annual revenue, build a trillion dollars in global GDP, and create 10 million jobs.Since its founding in 2010, 1Mby1M has become a powerful platform for democratization of entrepreneurship acceleration.Sramana also developed 1Mby1M's Incubator-in-a-Box methodology for Corporate Incubation that is used by enterprises to manage internal and external innovation endeavors.In 2015, LinkedIn named Sramana one of their Top 10 Influencers alongside Bill Gates and Richard Branson.Sramana has been an entrepreneur and a strategy consultant in Silicon Valley since 1994. Her fields of experience span from hardcore technology disciplines like Artificial Intelligence, Cloud Computing and Semiconductors, to sophisticated consumer marketing industries including e-commerce, fashion and education.As an entrepreneur CEO, Sramana founded three companies: Dais (off-shore software services), Intarka (sales lead generation and qualification software using Artificial Intelligence algorithms; VC: NEA) and Uuma (online personalized store for selling clothes using Expert Systems software; VC: Redwood). Two of these were acquired, while the third received an acquisition offer from Ralph Lauren which the company did not accept.As strategy consultant, Sramana has consulted with over 80 companies, including public companies such as SAP, Cadence Design Systems, Webex, KLA-Tencor, Best Buy, MercadoLibre and Tessera among others. Her work has also included numerous startups and VCs.Sramana has a Masters degree in EECS from MIT and a Bachelors degree in Computer Science and Economics from Smith College.From 2000 to 2004, Sramana chaired the MIT Club of Northern California's entrepreneurship program in Silicon Valley.Learn more at www.1Mby1M.com

In this episode, we welcome Jake Rubens, a seasoned genomic science entrepreneur and co-founder of Quotient Therapeutics. Tune in to hear Jake discuss the potential of somatic genomics (genes that are present in any cell in the body except for germline cells) in therapeutic development. As the founder of several companies, including Tessera and Sana Therapeutics, Jake offers his unique perspective on the advantages of utilising insights from somatic genome sequencing to understand disease mechanisms and discover new drug targets. He also shares valuable lessons from his robust entrepreneurial journey!

In questa puntata di Start parliamo di It wallet, il portafoglio digitale degli italiani, del lavoro attraverso le agenzie e di un campeggio urbano gratuito per i giovani designer che arriveranno a Milano per la Design week

In questa puntata di Start parliamo di It wallet, il portafoglio digitale degli italiani, del lavoro attraverso le agenzie e di un campeggio urbano gratuito per i giovani designer che arriveranno a Milano per la Design week

Audio Recording with permission by an active Legionary volunteer. No money whatsoever has been or will be taken for the podcast “Deepening Catholic Prayer” AMDG Carmel

Bruno Nacci"La tentazione di Sant'Antonio"Gustave FlaubertCarbonio Editorewww.carbonioeditore.itAbbandonata la sua casa, la famiglia e le sue ricchezze, sant'Antonio vaga per trent'anni nel deserto, tra scorpioni e sciacalli, patendo la fame e la sete, e mentre si ostina nel suo ascetismo, innumerevoli visioni fantastiche, prove dello spirito e dell'immaginazione, lo assediano e lo tormentano, riversandosi in abbacinanti scene pittoriche.Concepito, scritto e riscritto tra il 1845 e il 1872, La tentazione di sant'Antonio è una sorta di bestiario teologico, un ricettacolo di fantasie, timori, ossessioni, dove il disincanto verso la vita e il mondo si esprime in un affresco grottesco di rarapotenza, che ha l'ardire del sogno e l'ebbrezza della follia. Tessera dopo tessera, Flaubert comporrà il suo mosaico fantastico e mostruoso, sul modello dei grandi e visionari pittori fiamminghi a cui si era ispirato, mettendo in scena in tutto il suo allucinato fulgore la solitudine dell'uomo e il desiderio mai appagato di sublimazione.Gustave Flaubert (1821-1880) è tra i massimi scrittori dell'Ottocento europeo. Maestro assoluto nel controllo della forma, è al tempo stesso capace di costruire perfette macchine narrative, riprendendo più volte, in un arco di tempo anche considerevolmente lungo, le prime stesure, correggendole, integrandole o riscrivendole. In questo senso le date di pubblicazione delle sue relativamente poche opere letterarie sono ingannevoli: Madame Bovary (1857), Salammbô (1862), L'educazione sentimentale (1869), La tentazione di sant'Antonio (1874), Tre racconti (1877), Bouvard e Pécuchet (postumo, 1881). Ha lasciato un cospicuo epistolario di enorme valore, non solo documentario.Bruno Nacci ha curato classici della letteratura francese, da Chamfort a Nerval, e in particolare Blaise Pascal, su cui ha scritto il saggio La quarta vigilia. Gli ultimi anni di Blaise Pascal (2014). Ha pubblicato il noir L'assassinio della Signora di Praslin (2000); con Laura Bosio ha scritto i romanzi storici Per seguire la mia stella (2017), La casa degli uccelli (2020) e il saggio Da un'altra Italia (2014). Ha pubblicato le raccolte di racconti: La vita a pezzi (2018), Dopo l'innocenza (2019), Destini (2020), Congedo delle stagioni (2022) e il racconto lungo La fine del viaggio (2023).IL POSTO DELLE PAROLEascoltare fa pensarewww.ilpostodelleparole.itQuesto show fa parte del network Spreaker Prime. Se sei interessato a fare pubblicità in questo podcast, contattaci su https://www.spreaker.com/show/1487855/advertisement

Tessera of Brandon, is fresh, modern and state-of-the-art assistedliving and memory care facility designed to support residents'well-being.The apartments allow for maximum independence and the community spaceshelp keep you connected and engaged with options for outdoor dining,and places to gather like our event center.All of our studio, one and two bedroom floor plans at our retirementcommunity have been designed with your every move in mind. Eachsingle-occupancy senior apartment has its own private bathroom with araised vanity and walk-in shower and grab bars. There is also akitchenette with a refrigerator, sink, microwave and cabinets.Residents are invited to decorate their apartments, just another waywe want this to feel like your home.The apartments in the memory care neighborhood have their own privatebathroom and roll-in shower.1320 Oakfield Drive, Brandon, FL, United States, Florida(813) 607-6880https://www.tesserabrandon.com/Jill Andrew is the award-winning director of marketing and a U.S. ArmyVeteran who brings a wealth of knowledge to our senior living

In this episode, Matthew and Brileigh are joined by DeeZe. Deeze is a long time degen, former Director of Vibes at Tessera, and host of the We Do A Little Pod, a series of candid long-form conversations with guests mostly from the NFT art world. In this episode, Deeze tells us about his journey from Runescape's Grand Exchange to flipping CryptoPunks and how Ethereum can be considered a global multiplayer game. We share stories about psychedelics, good and bad trades, as well as his experience as an “influencer” and how he deals with the ethics and social dynamics of having a huge following. We also touch on why he's stayed anon over the years, Twitter's sudden rebrand, and why email is still the best decentralized social network. Chapters: 0:00:00 Intro 00:00:53 Disclaimer 00:01:30 Welcome 00:01:56 Twitter's rebrand and the “Twitter killer” apps 00:04:31 Comparing all the “Twitter killer” apps (Farcaster, Lens, Bluesky, Threads) 00:08:37 Where the name Deeze comes from 00:09:53 How Deeze went from trading on Runescape to flipping CryptoPunks 00:18:58 Parallels between MMORPGs like Runescape and crypto 00:22:06 Learning from mistakes, bad trades, and the screenshot rule 00:25:24 Deeze's approach to collecting art vs PFPs & the first artists he discovered 00:32:36 Learning to save gains for taxes 00:35:56 Discussing some of Deeze's favourite 1/1 art NFTs from his collection 00:41:41 Deeze's relationship to weed 00:48:15 Guns, Ian McDougall, boat people, and other stories of psychedelic experiences 01:00:27 Feeling the vibrations, the 6529 thread, and other life lessons 01:12:18 How Deeze handles the ethics and social dynamics of having a huge following 01:21:09 Why Deeze chose to be anon and dealing with targeted attacks 01:29:34 The power of memetics and trading shitcoins 01:46:18 We Do A Little podcast 01:48:53 Wrap up Topics discussed Decentralized social media CryptoPunks Cath Simard Skulls of Luci - The Eye of Exodus Chromie Squiggles Pop wonder Killer Acid Matt Kane King Xerox Zaid Kirdsey Jubbish Jay Summer Wagner Brooke Didonato Wooden Cyclops Lurk Loves You Thousand Finger Man - Candido Punk 6529 Thread Pepe, HarryPotterObamaSonic10Inu, and other shitcoins Crypto influencers We Do A Little Podcast Relevant links Follow DeeZe on Twitter: @DeeZe We Do A Little Podcast: @wedoalittlepod Sign up for the ⁠Juicebox newsletter⁠ Create a Juicebox project: juicebox.money Browse ⁠trending projects on Juicebox Follow Juicebox on Twitter: ⁠@juiceboxETH⁠ Book an onboarding session with a contributor juicebox.money on Twitter: @juicebox_money Follow Matthew on Twitter: ⁠@0xmatthewb⁠ Follow Brileigh on Twitter: ⁠@0xbrileigh⁠ Credits Hosts: Matthew and Brileigh Production: Matthew and Brileigh Engineering: Matthew Music: EastAndW by Romariogrande Disclaimer: The contents of The Juicecast are strictly for educational and entertainment purposes only. This podcast is not financial advice or a solicitation to buy or sell any assets or to make any financial decisions. Do not purchase any tokens discussed on episodes of The Juicecast in anticipation of financial gains. Please do your own research.

In this episode, Patrick is joined by Dr. Mike Severino, CEO of Tessera Therapeutics and CEO-Partner of Flagship Pioneering. Join us as Mike walks us through Tessera's approach to treating genetic diseases by rewriting bases, exons, or even whole genes with a novel approach called Gene Writing. 0:00 Intro 1:00 What prompted you to join Flagship Pioneering? 3:32 How is Flagship able to innovate and invent novel therapies in ways that Big Pharma companies may find difficult? 5:00 Introduction to gene writing and the role of Tessera Therapeutics 8:22 The current limitations and challenges of gene writing 10:22 Gene knockouts vs gene writing – which is more useful for genetic therapies? 12:30 Reasons why the liver the most commonly targeted organ for gene therapies 19:00 Lipid Nanoparticles and their role in gene writing 22:45 How do you guide mobile genetic elements to write genes in the intended location? 25:20 Development of gene writing technology since 2018 28:15 The implications of gene writing for diseases like PKU, Alpha-1 antitrypsin deficiency, sickle cell disease, and cancer 34:00 Next steps on the way to clinical trials 36:46 Using genomics and computational biology to guide measurable outcomes in drug discovery and development 40:15 Using gene writing to address rare developmental diseases 43:32 Closing remarks

In this episode, Patrick is joined by Dr. Mike Severino, CEO of Tessera Therapeutics and CEO-Partner of Flagship Pioneering. Join us as Mike walks us through Tessera's approach to treating genetic diseases by rewriting bases, exons, or even whole genes with a novel approach called Gene Writing. 0:00 Intro 1:00 What prompted you to join Flagship Pioneering? 3:32 How is Flagship able to innovate and invent novel therapies in ways that Big Pharma companies may find difficult? 5:00 Introduction to gene writing and the role of Tessera Therapeutics 8:22 The current limitations and challenges of gene writing 10:22 Gene knockouts vs gene writing – which is more useful for genetic therapies? 12:30 Reasons why the liver the most commonly targeted organ for gene therapies 19:00 Lipid Nanoparticles and their role in gene writing 22:45 How do you guide mobile genetic elements to write genes in the intended location? 25:20 Development of gene writing technology since 2018 28:15 The implications of gene writing for diseases like PKU, Alpha-1 antitrypsin deficiency, sickle cell disease, and cancer 34:00 Next steps on the way to clinical trials 36:46 Using genomics and computational biology to guide measurable outcomes in drug discovery and development 40:15 Using gene writing to address rare developmental diseases 43:32 Closing remarks

La food card della Meloni e il vertice Nato. Oscar Giannino, Don Chisciotte, ne parla con Carlo Alberto Carnevale Maffé, Ronzinante, e Renato Cifarelli, Sancho Panza.Per supportarci potete farlo quiwww.donchisciottepodcast.itSee omnystudio.com/listener for privacy information.

My guest this week is Adam Sternbach (https://twitter.com/adamsternbach ), General Counsel of Tessera (https://twitter.com/tessera ). Adam has been on the frontlines of the legal side of web3 since 2021, but has been on a lifelong journey to make things better. After a brief career on the public side, he turned his sites to private practice and the startup world to make a bigger impact. He has one of the most comprehensive understandings of the current state of US regulation, and provides countless examples of how we as a community in web3 can educate lawmakers and others to help provide legitimacy to the space. We Discuss: The difference of making an impact on society through the public and private sectorTessera's latest release - Escher - providing a single pane of glass for collectors and artistsThe future of State vs Federal regulation of digital assets, and why it is important to educate as to the nuances between different uses of the technologyHow web3 provides the individual with so much empowerment to make the world a better place and have upside in outcomes of the technology Chapters00:00 Introduction to Adam and How to Make Things Happen09:51 Adam's Web3 Background 2013-Now17:01 What is Tessera and Escher?21:40 Education: How to Make an Impact on Policy Makers32:22 Consumer Protection Outside Regulation37:00 Tribalism and the Moral High Ground48:25 Closing Questions - What is Web3? What is the future?Thanks for listening! Did you know you can also watch the show on YouTube? Just hit the link below and don't forget to subscribe!Web3 w/ Me - YouTube

In this latest episode of GoodWill Yunting, we talk all thing crypto regulation and politics with Adam of Tessera. We get in depth on the current regulatory and political landscape surrounding crypto. We talk the Biden administration's stance, how Gary and the SEC views crypto, and the common misconceptions about crypto from media portrayal. Bew and I ask how can the tide change when it comes to shifting the view of crypto in the eyes of the SEC and politicians alike. We discuss how harnessing the grass-roots nature of crypto can be a powerful tool to help move the industry forward for the better in the eyes of regulators and politicians. Of course, we can't talk regulation without discussing FTX and Luna and the coming repercussions of those blowups. Adam drops a bomb on Bew that blows his mind for the rest of the episode as well. We dive deep into some of the latest crypto regulation cases and actions such as Kraken, Ripple, stablecoins and more. This episode is filled with tons of insight into the future of politics and regulation around crypto, and what we as an industry can do to fight back. Don't sleep on this brilliant episode!  If you enjoyed the episode, please subscribe, rate, and share so we can continue to get amazing, alpha dropping guests. We plan to release episodes bi-weekly, so don't sleep!   Big thank you to Xan for taking the time out of his day to talk crypto with us. You can find them on Twitter @Sathematical and @0xDoug.  Feel free to tweet or message me @TheRogueItachi. You can find the pod on Twitter @GoodWillYunting As always, Yunt Hard, Yunt Fast, Yunt Capital.  Disclaimer: Nothing said on this podcast is advice or a solicitation to buy or sell any assets or tokens. We may, and often because we're passionate about the projects we bring on, hold investments in the project and even work in their communities. None of this is financial advice, please do your own research; this is a risky field. 

Ep 60: Bancomat, carte di credito, schedine del telefono, tessere sanitarie, carte d'identità elettroniche, carte servizio di varia natura, tessere universitarie, la smart card è applicabile a una varietà incredibile di soluzioni, ma pochissimi conoscono il nome e la storia di Roland Moreno, imprenditore francese autodidatta, nato al Cairo, che ne ha depositato il brevetto il 25 marzo1974.

SPECIAL EDITION: BOB@JPMFlagship Pioneering plucked Michael Severino, M.D. away from AbbVie to run point at Tessera, a startup it's backed to pioneer a new category of genetic medicine it calls gene writing. The Business of Biotech caught up with Severino at the JP Morgan Healthcare Conference in San Francisco last month. We learned what lured him away from leadership positions at Merck, Amgen, and AbbVie, how gene writing differs from gene therapy and gene editing, why the team at Tessera believes its technologies can write and rewrite DNA at the scales necessary to cure most genetic diseases, and where he plans to take the company from here. Subscribe to the NEW #BusinessofBiotech newsletter at bioprocessonline.com/bob for more real, honest, transparent interactions with the leaders of emerging biotech. It's a once-per-month dose of insight and intel that you'll actually look forward to receiving! Check it out at bioprocessonline.com/bob!

TylerD, Ghost and Emily are joined by legendary NFT trader and collector DeezeFi for a longer discussion to talk about the overall crypto and NFT market, if we're due for a pullback and why he faded Checks. Then Andy8052 (founder of Tessera) joins the crew to talk about the open edition meta, the launch of Escher and how Escher solves the legacy issues in the art edition market. The group then chats generative art and Memes before closing out.

Lou and Tyler sit down with @andy8052 to chat about what's new with Tessera. Tessera's recently launched its new platform for collective ownership, a marketplace, and a new protocol.

In this episode, we discuss the 26th Degree - “Prince of Mercy” as we continue our exploration of "Morals & Dogma: The Annotated Edition". It is highly recommended that you read the chapter in order to fully follow our discussion."Morals and Dogma" is available from these sites:Albert Pike's Morals and Dogma: Annotated Edition (to purchase)Morals and Dogma (free but unannotated online PDF)Albert Pike's Morals and Dogma (Audible audiobook for purchase)Images and Diagrams:26th Degree - Apron, Cordon and JewelJerusalem (by William Blake)Overview:Introduction (01:14)The Greater Mysteries (1:43)Degree Ritual (03:46)Purpose of the Degree (09:01)Morals and Dogma (09:57)The Great Reformers (10:17)Unseen Miracles (10:57)The Triple Triangle (13:09)The Three Sacraments (15:03)Beyond the Demiurge (18:07)First Cause (20:19)Where Do Thoughts Come From? (21:28)The Masonic Trinity (23:25)Palladium - Pallas Athene (24:59)Tessera (27:30)Conclusions (29:57)Links:Scottish Rite Ritual Monitor & Guide (Amazon)A Bridge to Light (Amazon)The History of the Christian Religion (Amazon)Palladium (Wikipedia)Athena (Wikipedia)Nashville Parthenon (NashvilleParthenon.com)Notarikon (Wikipedia)Gematria (Wikipedia)Yahweh (Wikipedia)Elohim (Wikipedia)Demiurge (Wikipedia)Yaldabaoth (Wikipedia)The Jesus Prayer (Wikipedia)Philip K. Dick (Wikipedia)William Blake vs The World (Audible)

Tessera joined the stage today to discuss their new project initiative Nounlets. They offer buyers a piece of ownership and governance over an actual Noun asset. By utilizing clever smart contracts they have made it to where there can be a new collections of assets for each Noun. They are pushing the boundaries on what can be done with an NFT. GM Hosted on Acast. See acast.com/privacy for more information.

Fractional — a crypto startup whose tech allows individual non-fungible tokens (NFTs) to be locked in a smart contract, and then 'fractionalized' into fungible digital pieces — is changing its name to 'Tessera.'  In addition to the name change, Tessera announced they closed a $20 million Series A earlier this summer in a funding round led by Paradigm. In this episode of The Scoop, Tessera co-founder and CEO Andy Chorlian explains how fractionalized NFTs foster new digital communities, and why 'Tessera' is a more suitable name for the direction of the platform. According to Chorlian, Tessera is helping new communities form by taking 'blue-chip' NFTs that could cost tens or hundreds of thousands of dollars, and making them more accessible to the average collector: "It's really just reshaping what it is that's exciting about a particular NFT or owning that NFT — generally more so in like the collecting things that you love and meeting other like minded people and being in interesting communities." The team decided to move away from 'Fractional' — a name that "sounds like a DeFi protocol," according to Chorlian — in favor of 'Tessera' because of the word's dual meaning and resonance with the vision for the platform: "It is the name of a tile used to create mosaic artwork, and the other use… is the idea of a membership pass or an identity card, and that really hit two of the main things that we think our product and NFTs in general are cool and exciting for." Episode 77 of Season 4 of The Scoop was recorded remotely with The Block's Frank Chaparro and Tessera co-founder and CEO Andy Chorlian. Listen below, and subscribe to The Scoop on Apple, Spotify, Google Podcasts, Stitcher or wherever you listen to podcasts. Email feedback and revision requests to podcast@theblockcrypto.com. This episode is brought to you by our sponsors Tron, Chainalysis &IWC Schaffhausen About Tron On August 1st, 2022, Poloniex launched a faster and more stable trading system along with a brand new user interface. Poloniex was founded in January 2014 as a global cryptocurrency trading platform. With its world-class service and security, it received funding in 2019 from renowned investors, including H.E. Justin Sun, Founder of TRON. Poloniex supports spot and margin trading as well as leveraged tokens. Its services are available to users in nearly 100 countries and regions with various languages available. For more information visit Poloniex.com About Chainalysis Chainalysis is the leading blockchain data platform. We provide data, software, services, and research to government agencies, exchanges, financial institutions, and insurance and cybersecurity companies in over 60 countries. Backed by Accel, Addition, Benchmark, Coatue, Paradigm, Ribbit, and other leading firms in venture capital, Chainalysis builds trust in blockchains to promote more financial freedom with less risk. For more information, visit www.chainalysis.com. About IWC Schaffhausen IWC Schaffhausen is a Swiss luxury watch manufacturer based in Schaffhausen, Switzerland. Known for its unique engineering approach to watchmaking, IWC combines the best of human craftsmanship and creativity with cutting-edge technology and processes. With collections like the Portugieser and the Pilot's Watches, the brand covers the whole spectrum from elegant timepieces to sports watches. For more information, visit IWC.com

In questo episodio vi propongo una bellissima intervista con Fabio Toscana, capo enologo del gruppo Mezzacorona che lavora in azienda da oltre 40 anni e ci racconta come è nata l'idea di un progetto sartoriale, di boutique wines, con etichette numerate a mano e uve super selezionate, all'interno di un'azienda di grandi dimensioni, come appunto il gruppo Mezzacorona. Parliamo di quanto conta la precisione, la tessera di un mosaico (Musivum significa mosaico in latino ed è il nome della nuova linea di vini), nel grande quadro d'insieme.Leggi di più su questo argomento sul mio blog www.theitalianwinegirl.itOppure sul sito di Mezzacorona: https://www.mezzacorona.it/it/prodotti/musivum Seguimi su Instagram per aggiornamenti quotidiani @theitalianwinegirl 

Jacob(Jake)Rubens, Co-Founder, Chief Innovation Officer Jake is Co-Founder and Chief Innovation Officer of Tessera Therapeutics, as well as a Principal at Flagship Pioneering. Jake joined Flagship Pioneering in 2015 and works as part of a venture-creation team, founding and growing companies based on new biotechnology. At Flagship, Jake launched Kaleido Biosciences and co-founded Sana Biotechnology. Jake was the Head of Innovation at Cobalt Biomedicine, where he invented and developed the company's Fusosome platform prior to its merger with Sana Biotechnology. Before joining Flagship, Jake received his Ph.D. in microbiology from MIT, working in the Synthetic Biology Center with Professor Tim Lu with the support of a National Science Foundation Graduate Research Fellowship. At MIT Jacob invented gene circuits that allow engineered cells to do novel analog, digital, and hybrid computations, enabling the emerging field of “intelligent” cell therapies. Jake's work has resulted in multiple pending patents and publications, including articles in Nature and Nature Communications. Jake was honored in 2017 in Forbes' 30 under 30 list in science. Hari Pujar, Chief Operating Officer Hari is Chief Operating Officer of Tessera, as well as Operating Partner at Flagship Pioneering. At Tessera, his responsibilities span across research, manufacturing, program strategy and management and IP. Hari is a global Biopharmaceutical executive with 20+ years of value creation in the biologics and vaccine industry. Before Flagship, Hari served as Chief Technology Officer of Spark Therapeutics, leading the technical operations, process and technology development and quality assurance organizations. At Spark, Hari was responsible for growing and scaling the company's cutting-edge technology capabilities for an expanding development pipeline. Prior to Spark, Hari was head of Technical Development & Manufacturing at Moderna Therapeutics. At Moderna, he built and led the technology and early manufacturing organizations that delivered on supply for more than a dozen clinical programs in a brand-new technology area. Previously, Hari held a variety of scientific and cross-functional leadership positions during 18+ years at Merck & Co in the company's commercial, R&D and manufacturing divisions, culminating in the franchise leadership of pediatric and adult vaccines representing over $2B in revenue. Hari has a Ph.D. in Chemical Engineering from the University of Delaware and an MBA from the Wharton School at the University of Pennsylvania. He is a Fellow of the American Chemical Society and the American Institute of Medical and Biological Engineers.

Today were talking about finance. How should Christians think about and tend to money and wealth without it becoming a deity? Steve's friends, Matt and Drew, join Tesserae for a conversation so needed in the Church! Listen until the end for some practical tips you can take for your own personal finance journey, and remember to join the conversation!

Yea, it's time to we go there... Join Steve and Bob for a frank conversation about marriage and singleness in the Church—the good, the bad and the ugly. Whether you are currently single or married, we would love for you to listen in and, as usual, be a part of the conversation! As always, you can find us on Instagram, Facebook, and Twitter @tessaraepodcast.

On this episode we tackle the prosperity gospel: what it is and why it's so prevalent. Join us as we explore the social and theological factors that fuel the prosperity gospel.  As always, we'd love to hear from you. Find us on social media (we're now on Insta!) at @tesseraepodcast. 

Steve reflects on the legacy of Dr. Martin Luther King, Jr., and shares an excerpt from one of King's early sermons!

Are you still unwell? Join us for part 2 of our discussion on wellness with Steve Durgin! This time we explore place and race in regards to wellness, as well as talk about some practical tips towards collective and individual wellness as believers! Give it a listen and tell us your thoughts!

Our hiatus is over! Self-care, learning to say no, taking care of your body, etc. Join Steve and co-host Steve Durgin as we begin to unpack the concept of wellness for Christians, as well as the industry that has helped make it a national conversation!